To be positively selected, immature thymocytes must receive signaling throu
gh their T-cell receptor (TCR), and engagement of relatively low-affinity s
elf-peptides permits further T-cell maturation. However, mature T cells no
longer overtly respond to such low-affinity antigens, indicating that T cel
ls acquire a higher threshold for activation during thymopoiesis. We wonder
ed whether partial interference in positive selection could produce T cells
that respond to the selecting self-peptide. This possibility was tested by
injecting procainamide-hydroxylamine (PAHA), a lupus-inducing drug, into t
he thymus of adult normal mice. Three weeks after the second injection, IgG
antichromatin antibodies appeared in the circulation and remained for seve
ral months. The murine antichromatin antibodies reacted with the (H2A-H2B)-
DNA subnucleosome complex, the predominant specificity in patients with pro
cainamide-induced lupus. In thymus organ and reaggregate cultures, PAHA had
no effect on negative selection of T cells with high affinity for a co-pre
sent antigen, but acted on CD4(+)CD8(+) immature T cells as they underwent
positive selection. TCR transgenic T cells specific to cytochrome c peptide
88-104 acquired the capacity to respond to the low-affinity analogue at po
sition 99 (lys --> ala) if PAHA was present during their development. PAHA
also blocked the capacity of a T-cell line to become anergic after anti-CD3
treatment, suggesting that PAHA prevents the production of negative regula
tors that accumulate in response to partial signaling through the TCR. Thes
e results are consistent with the view that T cells acquire self-tolerance
during positive selection, and disruption of this process can result in aut
oreactive T cells and systemic autoimmunity.